Qu01: A Prospective Observational Case Series of a Four-ring-haptic Acrylic One-piece IOL

Sponsor
General Hospital Linz (Other)
Overall Status
Completed
CT.gov ID
NCT01244373
Collaborator
Department of ophthalmology, General Hospital Linz (Other)
9
1
15
0.6

Study Details

Study Description

Brief Summary

To describe biocompatibility, postoperative results and complications after implantation of the Corneal Quatrix Evolutive (Corneal, Croma, Austria) intraocular lens, a hydrophilic acrylic intraocular lens (IOL) with 4-haptic design and 360° sharp optic edge.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    In this prospective case series the Corneal Quatrix Evolutive IOL was implanted in 14 eyes of nine patients with senile cortico-nuclear cataract. A standardized surgical technique and post-operative regimen were applied. Six months postoperatively best corrected visual acuity (BCVA), refraction and complications (especially) posterior capsule opacification (PCO) were analysed.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    9 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Observational Case Series of the Implantation of Intraocular Lens "QUATRIX® Aspheric Evolutive Pre-loaded".
    Study Start Date :
    May 1, 2008
    Actual Primary Completion Date :
    Aug 1, 2009
    Actual Study Completion Date :
    Aug 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    Patients with senile cataract

    Patients with senile cataract

    Outcome Measures

    Primary Outcome Measures

    1. Best-corrected visual acuity (BCVA) [Six months]

      The best-corrected visual acuity is assessed with glasses after cataract operation

    Secondary Outcome Measures

    1. Posterior capsule opacification [Six months]

      The posterior capsule opacification is assessed by slit lamp examination and subjective grading

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    Patients with senile cortico-nuclear cataracts without previous intraocular surgery

    Exclusion Criteria:
    • Dilated pupil size of < 6 mm

    • long-term anti-inflammatory treatment

    • previous history of intraocular surgery

    • previous history of corneal endothelial damage

    • previous history of ocular trauma

    • traumatic cataract

    • history of uveitis

    • diabetic retinopathy

    • advanced macular degeneration

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of ophthalmology, General Hospital Linz Linz Upper Austria Austria 4021

    Sponsors and Collaborators

    • General Hospital Linz
    • Department of ophthalmology, General Hospital Linz

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01244373
    Other Study ID Numbers:
    • Quatrix01
    First Posted:
    Nov 19, 2010
    Last Update Posted:
    Nov 19, 2010
    Last Verified:
    Nov 1, 2010

    Study Results

    No Results Posted as of Nov 19, 2010